Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ortho Clinical Diagnostics Plc (OCDX)

Ortho Clinical Diagnostics Plc (OCDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Quidel and Ortho Announce Expected Closing of Ortho Transaction

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions,...

OCDX : 17.63 (+0.46%)
QDEL : 46.23 (-0.26%)
Quidel and Ortho Announce Expected Closing of Ortho Transaction

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings...

QDEL : 46.23 (-0.26%)
OCDX : 17.63 (+0.46%)
Ortho Clinical Diagnostics Shareholders Approve Quidel Transaction

RARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho” or the “Company”), one of the world’s...

OCDX : 17.63 (+0.46%)
QDEL : 46.23 (-0.26%)
Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2022 Earnings Call Transcript

OCDX earnings call for the period ending March 31, 2022.

OCDX : 17.63 (+0.46%)
Ortho Clinical Diagnostics Recognized with Fifth Prestigious Edison Award for Highly Accurate COVID-19 Solution

Gold Award Recognizes Antibody Test...

OCDX : 17.63 (+0.46%)
Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022

RARITAN, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro...

OCDX : 17.63 (+0.46%)
Ortho Clinical Diagnostics Wins Bronze Stevie® Award for Customer Service and Support

Ortho Care® Service and Support recognized for dedication to solving customer challenges with unique solutions that deliver exceptional patient care...

OCDX : 17.63 (+0.46%)
Ortho Clinical Diagnostics Holdings plc (OCDX) Q4 2021 Earnings Call Transcript

OCDX earnings call for the period ending December 31, 2021.

OCDX : 17.63 (+0.46%)
Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 Results

Strong Revenue Growth Drives Financial Results...

OCDX : 17.63 (+0.46%)
Ortho Clinical Diagnostics Holdings Plc (“Ortho”): Notice of UK Court Scheme Directions Hearing

RARITAN, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Further to the joint announcement by Ortho and Quidel Corporation (“Quidel”) on December 23, 2021 of the...

OCDX : 17.63 (+0.46%)

Barchart Exclusives

Dividend Aristocrats: The Best of the Best for Stable Income
Dividend Aristocrats' ability to increase their dividends indicates strong earnings and a solid business foundation, which lowers investment risk. Moreover, their consistent earnings growth often enables them to outperform broader market indices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar